Detalles de la búsqueda
1.
The Potential for Immunospecific Therapy in Multiple Sclerosis Based on Identification of Driver Clones of the Disease.
Crit Rev Immunol
; 40(3): 237-246, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33389887
2.
MicroRNA-192-5p is a predictive biomarker of survival for Stage IIIB colon cancer patients.
Jpn J Clin Oncol
; 48(7): 619-624, 2018 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29529220
3.
Chip-based platform for dynamic analysis of NK cell cytolysis mediated by a triplebody.
Analyst
; 141(7): 2284-95, 2016 Apr 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-26958659
4.
NK cells from an AML patient have recovered in remission and reached comparable cytolytic activity to that of a healthy monozygotic twin mediated by the single-chain triplebody SPM-2.
J Transl Med
; 11: 289, 2013 Nov 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-24237598
5.
Spectratyping analysis of the islet-reactive T cell repertoire in diabetic NOD Igµ(null) mice after polyclonal B cell reconstitution.
J Transl Med
; 9: 101, 2011 Jul 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-21722394
6.
Treatment combining RU486 and Ad5IL-12 vector attenuates the growth of experimentally formed prostate tumors and induces changes in the sentinel lymph nodes of mice.
J Transl Med
; 8: 98, 2010 Oct 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-20946663
7.
Attenuation of the glucocorticoid response during Ad5IL-12 adenovirus vector treatment enhances natural killer cell-mediated killing of MHC class I-negative LNCaP prostate tumors.
Cancer Res
; 67(5): 2290-7, 2007 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17332360
8.
Dual-targeting triplebody 33-16-123 (SPM-2) mediates effective redirected lysis of primary blasts from patients with a broad range of AML subtypes in combination with natural killer cells.
Oncoimmunology
; 7(9): e1472195, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30228941
9.
Systematic immunohistochemical screening for mismatch repair and ERCC1 gene expression from colorectal cancers in China: Clinicopathological characteristics and effects on survival.
PLoS One
; 12(8): e0181615, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28767665
10.
A relationship to survival is seen by combining the factors of mismatch repair status, tumor location and age of onset in colorectal cancer patients.
PLoS One
; 12(3): e0172799, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28253296
11.
Evidence for an Association of ERCC1 Expression and Mismatch Repair Status with Overall Survival in Colorectal Cancer Patients.
Oncol Res Treat
; 40(11): 702-706, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29065415
12.
Impact of age and mismatch repair status on survival in colorectal cancer.
Cancer Med
; 6(5): 975-981, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28345223
13.
Association between Ki67 Index and Clinicopathological Features in Colorectal Cancer.
Oncol Res Treat
; 39(11): 696-702, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27855388
14.
Dual-targeting triplebody 33-3-19 mediates selective lysis of biphenotypic CD19+ CD33+ leukemia cells.
Oncotarget
; 7(16): 22579-89, 2016 Apr 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-26981773
15.
CD19-specific triplebody SPM-1 engages NK and γδ T cells for rapid and efficient lysis of malignant B-lymphoid cells.
Oncotarget
; 7(50): 83392-83408, 2016 Dec 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-27825135
16.
T cell-recruiting triplebody 19-3-19 mediates serial lysis of malignant B-lymphoid cells by a single T cell.
Oncotarget
; 5(15): 6466-83, 2014 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25115385
17.
Two Domains of Vimentin Are Expressed on the Surface of Lymph Node, Bone and Brain Metastatic Prostate Cancer Lines along with the Putative Stem Cell Marker Proteins CD44 and CD133.
Cancers (Basel)
; 3(3): 2870-85, 2011 Jul 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-24212937
18.
Life-long systemic protection in mice vaccinated with L. major and adenovirus IL-12 vector requires active infection, macrophages and intact lymph nodes.
Vaccine
; 23(2): 247-57, 2004 Nov 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-15531044
19.
Protection against experimental autoimmune encephalomyelitis generated by a recombinant adenovirus vector expressing the V beta 8.2 TCR is disrupted by coadministration with vectors expressing either IL-4 or -10.
J Immunol
; 170(2): 765-74, 2003 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12517939
Resultados
1 -
19
de 19
1
Próxima >
>>